Insulin Drug Study Shows Significant Improvements In More Than 52,000 Diabetic Patients
A major international diabetes study of more than 52,000 patients from eight countries has shown that using biphasic BIAsp 30 insulin resulted in significant clinical improvements and greater patient satisfaction. The findings, reported in the March issue of IJCP, the International Journal of Clinical Practice, show that 53 per cent achieved a blood glucose (HbA1c) level of less than seven per cent, the target set by the International Diabetes Foundation.
Leave a Reply
You must be logged in to post a comment.